Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David San Segundo

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
International Immunology|August 14, 2015
High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantationFrancisco Boix-Giner, Olga Millan, David San Segundo, et al.
Transplantation|March 24, 2022
Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant RecipientsAitor Odriozola, Patricia Lamadrid-Perojo, Antonio Cuadrado, et al.
Transplantation Proceedings|November 1, 2022
Non-HLA Antibodies and Their Role in Highly Sensitized PatientsAdriel Roa-Bautista, Covadonga López-Del-Moral, Elena González-López, et al.
Immunobiology|February 7, 2016
High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipientsFrancisco Boix, Olga Millan, David San Segundo, et al.
Hepatology Communications|March 28, 2022
Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipientsAntonio Cuadrado, María Del Barrio, José Ignacio Fortea, et al.
Vaccines|December 28, 2021
COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health DecisionDavid San Segundo, Alejandra Comins-Boo, Patricia Lamadrid-Perojo, et al.
Transplantation|August 6, 2014
Antibody-mediated rejection: analyzing the risk, proposing solutionsManuel Arias, David N Rush, Chris Wiebe, et al.
Human Immunology|April 25, 2024
Low-risk delisting strategy in highly sensitized patients without donor offers included in exchange donation programs. One single-center experienceAlejandra Comins-Boo, Juan Irure-Ventura, Maria O Valentin, et al.
Biomedicines|April 2, 2020
Immunosuppression with Calcineurin Inhibitor after Renal Transplant Failure Inhibits AllosensitizationCovadonga López Del Moral Cuesta, Sandra Guiral Foz, David Gómez Pereda, et al.
Transplantation Reviews (Orlando, Fla.)|April 10, 2025
Spanish guidelines for kidney transplantation in highly sensitized patients with donor-specific anti-HLA antibodiesEsther Mancebo, Fritz Diekmann, Eduard Palou, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
International Immunology|August 14, 2015
High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantationFrancisco Boix-Giner, Olga Millan, David San Segundo, et al.
Transplantation|March 24, 2022
Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant RecipientsAitor Odriozola, Patricia Lamadrid-Perojo, Antonio Cuadrado, et al.
Transplantation Proceedings|November 1, 2022
Non-HLA Antibodies and Their Role in Highly Sensitized PatientsAdriel Roa-Bautista, Covadonga López-Del-Moral, Elena González-López, et al.
Immunobiology|February 7, 2016
High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipientsFrancisco Boix, Olga Millan, David San Segundo, et al.
Hepatology Communications|March 28, 2022
Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipientsAntonio Cuadrado, María Del Barrio, José Ignacio Fortea, et al.
Vaccines|December 28, 2021
COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health DecisionDavid San Segundo, Alejandra Comins-Boo, Patricia Lamadrid-Perojo, et al.
Transplantation|August 6, 2014
Antibody-mediated rejection: analyzing the risk, proposing solutionsManuel Arias, David N Rush, Chris Wiebe, et al.
Human Immunology|April 25, 2024
Low-risk delisting strategy in highly sensitized patients without donor offers included in exchange donation programs. One single-center experienceAlejandra Comins-Boo, Juan Irure-Ventura, Maria O Valentin, et al.
Biomedicines|April 2, 2020
Immunosuppression with Calcineurin Inhibitor after Renal Transplant Failure Inhibits AllosensitizationCovadonga López Del Moral Cuesta, Sandra Guiral Foz, David Gómez Pereda, et al.
Transplantation Reviews (Orlando, Fla.)|April 10, 2025
Spanish guidelines for kidney transplantation in highly sensitized patients with donor-specific anti-HLA antibodiesEsther Mancebo, Fritz Diekmann, Eduard Palou, et al.
Pageof 9